Sam Bankman-Fried requests long-acting Adderall to focus during trial

FTX co-founder Sam Bankman-Fried has asked a United States justice for long-release Adderall, saying he’s uncovering it hard to ore decently during his transgression trial.

In an Oct. 15 missive to New York District Judge Lewis Kaplan, Bankman-Fried’s lawyers asked if Bankman-Fried could instrumentality a “12-hour extended-release 20mg dose of Adderall” earlier he’s transported to proceedings connected Oct. 16.

The lawyers added that Bankman-Fried’s deficiency of the prescribed stimulant during proceedings hours means he’s “not been capable to ore astatine the level helium ordinarily would” and wouldn’t beryllium capable to “meaningfully participate” successful presenting his defense.

The erstwhile FTX CEO has been “doing his champion to stay focused during the trial” contempt his deficiency of medicine during proceedings hours, the missive added.

Even if Bankman-Fried takes the requested medication, there’s “no mode of knowing astatine contiguous whether the extended-release dose volition beryllium effective,” his lawyers said.

Related: Caroline Ellison wanted to measurement down but feared a slope tally connected FTX

They requested the tribunal halt the proceedings for 1 time — connected Tuesday, Oct. 17 — if Bankman-Fried was either incapable to instrumentality the long-release dose oregon if the medicine didn’t enactment truthful they could “find a solution that volition enactment for the remainder of [the] trial.”

Alternatively, the lawyers requested that Judge Kaplan licence them to supply Bankman-Fried with his medicine of Adderall astatine the District Court during the trial.

The lawyers claimed they had attempted to lick the contented with the Bureau of Prisons, but had not received a effect to “numerous emails and dependable messages.”

Magazine: Blockchain detectives — Mt. Gox illness saw commencement of Chainalysis